ViTAA Medical Solutions

Montreal, Quebec, Canada All Canada companies → — Founded 2019

Imaging AI Specialist Specialty-Focused AI

Cardiology Cardiothoracic Surgery Radiology Vascular Surgery

Cardiology AI Radiology & Imaging AI Surgical AI

Series A

Claim this company

Products

AiORTA – Plan

ViTAA Medical Solutions Inc.

Radiology & Imaging AI

AiORTA - Plan is an FDA-cleared, AI-powered, web-based solution by ViTAA Medical Solutions that automates hyper-precise preoperative planning for aortic surgery, including aneurysm segmentation and volumetric analysis.

See all 1 product →

About ViTAA Medical Solutions

ViTAA Medical Solutions is a healthcare AI company focused on developing personalized medicine solutions for patients diagnosed with abdominal aortic aneurysms (AAAs). Their flagship product, RAW Mapping technology, utilizes AI and biomechanical analysis to assess the deformation of the aorta wall from cardiac-gated CT imaging data. This technology aims to provide physicians with detailed strength and weakness maps of the abdominal aortic aneurysm, incorporating critical simulation data on blood flow and intraluminal thrombus (ILT) within the aneurysm.

The company’s platform, the AiORTA™ Suite, is designed to redefine how clinicians understand and act on aneurysm risk. It offers a comprehensive system for surveillance, pre-operative planning, and post-operative monitoring. By moving beyond traditional size-based thresholds, which can be unreliable, ViTAA’s explainable AI helps identify high-risk patients more precisely, potentially preventing ruptures and guiding more appropriate interventions. The technology is currently used in research in over 40 North American hospitals under IRB approval and received FDA 510(k) clearance for its AiORTA Plan™ tool in November 2025.

Focus Areas

Personalized medicine abdominal aortic aneurysms AI diagnostic imaging aortic surgery planning vessel strength analysis longitudinal monitoring cloud-based solutions computer vision machine learning

Business Intelligence

Technology

AiORTA™ platform (Plan, Maps, Watch), RAW Mapping technology, cloud-based software, AI-assisted 3D modeling, computer algorithms, in vivo strain analysis, optical-flow algorithm

What Physicians Need to Know

Personalized Medicine & Abdominal Aortic Aneurysms (AAA)

ViTAA Medical Solutions specializes in redefining aortic aneurysm care by moving beyond outdated, population-based size thresholds for intervention. Their core innovation, RAW™ (Regional Areas of Weakness) mapping technology, analyzes the deformation of the aorta wall using cardiac-gated CT scans to create detailed strength and weakness maps of abdominal aortic aneurysms. This allows for patient-specific risk assessment, identifying high-risk aneurysms even when small, and protecting lower-risk patients from unnecessary surgeries.

AI & Diagnostic Imaging

ViTAA leverages AI and diagnostic imaging to assess aneurysms more accurately. Their AiORTA™ platform uses a 'glassbox' AI engine, meaning every prediction is auditable and transparent to the clinician, avoiding a 'black box' approach. The AI model was built from over a decade of ex vivo research using real human tissue and validated with over 200 aortic tissue samples, mechanical testing, histology, microscopy, and genetic analysis.

Aortic Surgery Planning

ViTAA's AiORTA™ Plan, which received FDA 510(k) clearance in November 2025, automates key preoperative measurements and streamlines aortic case preparation. The web-based system performs automated aneurysm segmentation, centerline extraction, precise diameter and angulation measurements, and instant volumetric modeling to provide highly accurate and reproducible results for surgical planning. It also evaluates the mechanical strength of the neck landing zone and surrounding tissue, aiding in stent selection and identifying patients who might benefit from more complex repairs.

Vessel Strength Analysis & Longitudinal Monitoring

The company's technology focuses on determining the actual strength of a patient's aorta, providing critical information to identify high-risk patients more precisely. ViTAA's AiORTA™ Maps help clinicians assess which aneurysms are stable and which show early signs of wall weakening. Their AiORTA™ Watch is designed for post-EVAR monitoring for early complication detection, tracking residual sac pressurization and identifying stable versus high-risk endoleaks to support timely clinical intervention.

Cloud-Based Solutions & Computer Vision/Machine Learning

ViTAA's solutions are delivered through a secure, cloud-based platform, eliminating the need for new hardware or capital expenses. This web-based application integrates smoothly into standard CT-based protocols and clinical workflows. The platform utilizes computer vision and machine learning algorithms to analyze imaging data and generate detailed strength and weakness maps of abdominal aortic aneurysms.

Physician Tip

ViTAA Medical Solutions offers physicians a paradigm shift in abdominal aortic aneurysm management by providing patient-specific insights into aortic wall strength, moving beyond traditional size-based guidelines. The AiORTA™ platform, with its explainable AI, allows for auditable predictions, fostering trust and deeper understanding. Physicians can utilize AiORTA™ Maps for early identification of high-risk aneurysms, even when small, and for stratifying patients during office visits with visual risk profiles. AiORTA™ Plan streamlines pre-operative planning with automated, hyper-precise measurements and strength assessments of landing zones. For post-operative care, AiORTA™ Watch enables longitudinal monitoring for early complication detection, such as residual sac pressurization and endoleaks. The cloud-based delivery ensures seamless integration into existing workflows without additional hardware, offering a unified platform for surveillance, planning, and follow-up across the entire aortic care journey. This technology aims to empower clinicians with actionable insights for confident patient management, potentially reducing unnecessary surgeries for low-risk patients and enabling timely intervention for high-risk individuals.

ViTAA Medical Solutions' platform is designed for workflow fit, integrating smoothly into standard CT-based protocols. As a cloud-based, zero-footprint web application, it avoids the need for new hardware or capital expenses, suggesting a focus on interoperability with existing hospital imaging and information systems. The company emphasizes scalability from individual users to full hospital systems, indicating a design that facilitates integration into broader healthcare IT infrastructures.

Products by ViTAA Medical Solutions

1 product in the directory

AiORTA – Plan

ViTAA Medical Solutions Inc.

Radiology & Imaging AI

What the Web Says

ViTAA Medical Solutions is a company focused on leveraging AI and medical imaging to improve the diagnosis, planning, and monitoring of abdominal aortic aneurysms (AAAs). Their flagship product suite, AiORTA, includes tools for tissue vulnerability mapping (AiORTA Maps™), automated preoperative planning (AiORTA Plan™), and post-EVAR monitoring (AiORTA Watch™). The company has received FDA clearance for its AiORTA Plan™ tool. While there is significant information about their technology and its potential, direct customer or employee reviews on platforms like G2, Glassdoor, Capterra, or Reddit are not readily available under the specific name "ViTAA Medical Solutions."

Overall: Positive

Strengths

Utilizes explainable AI and tissue-validated analysis for aneurysm care.
Offers a suite of tools for diagnosis, surgical planning, and post-operative monitoring of AAAs.
AiORTA Plan™ has received FDA 510(k) clearance.
Cloud-based and secure with no hospital software installation required.
Faster turnaround times compared to some legacy 3D planning tools.
Built-in QA analyst review for every case ensures data integrity.

Limitations

Limited public reviews from customers or employees on major platforms like G2, Glassdoor, Capterra, or Reddit.
AiORTA Maps™ and AiORTA Watch™ are not yet available for sale.
The analysis pipeline involves a trained analyst, with the end-user ultimately responsible for accuracy.

Based on reviews from: Boreal Ventures (Medium), STEVEN ARLESS (Medium), Fierce Biotech, ViTAA Medical Solutions Official Website, accessdata.fda.gov

Last updated: 2026-10-19

Videos

News, demos, and interviews about ViTAA Medical Solutions.

Loading videos...

Videos load interactively. If none appear, search YouTube for ViTAA Medical Solutions →

View all on YouTube

Press & Coverage

Financial Post (via Business Wire)

ViTAA Medical Secures FDA 510(k) Clearance for AiORTA™ Plan — Marking the First Step in Its Hyper-Precise Aortic Care Platform

ViTAA Medical Solutions Inc. announced FDA 510(k) clearance for AiORTA™ Plan, their automated aortic surgery planning solution, a key milestone for their broader AiORTA™ platform. This clearance validates their approach of combining automation with precision medicine for aortic care.

2025-11

ViTAA Medical Solutions

FDA Clears AiORTA™ Plan for Hyper-Precise Aortic Surgery Planning

ViTAA Medical Solutions Inc. received FDA 510(k) clearance for AiORTA™ Plan, a fully automated, hyper-precise aortic surgery planning solution that streamlines preoperative measurements and generates complete aortic plans in minutes. This is the first step in their platform strategy, which includes AiORTA™ Maps and AiORTA™ Watch currently in clinical studies.

2025-11

Vascular News

ViTAA Medical announces US FDA 510(k) clearance for aortic planning platform

ViTAA Medical announced that the US FDA has granted 510(k) clearance for AiORTA Plan, an automated, hyper-precise aortic surgery planning solution designed to streamline preoperative measurements. The company's broader AiORTA platform, including AiORTA Maps and AiORTA Watch, is currently undergoing multicenter clinical studies.

2025-11

Medical Device Network

FDA clears ViTAA Medical's AI aortic surgery planning tool

ViTAA Medical's AiORTA Plan has received FDA clearance, validating the company's approach of combining automation with precision medicine for aortic care. The company's CMO, Dr. Randy Moore, stated that ongoing clinical studies for AiORTA Maps and AiORTA Watch aim to provide solutions that offer insights into vessel behavior beyond traditional size guidelines.

2025-11

INOVAIT

From Risk to Hyper-Precision: How ViTAA Medical is leveraging imaging and AI to redefine Aortic Aneurysm Care

ViTAA Medical is using AI and imaging to transform aortic aneurysm care, moving beyond traditional size measurements to predict aneurysm rupture with high accuracy. In 2024, their AI system demonstrated 100% sensitivity and 92% specificity in predicting which aneurysms would rupture based on historical data.

2025-12

ResearchGate (Journal of Vascular Surgery Cases and Innovative Techniques)

A Multicenter Case Review Program on the Impact of ViTAA™ RAW Maps on Clinical Decision-Making in Abdominal Aortic Aneurysm Management

This article, published in October 2026, details a multicenter case review program investigating the impact of ViTAA™ RAW Maps on clinical decision-making for abdominal aortic aneurysm management. The study explores how ViTAA's technology influences surgical planning and patient care.

2026-10

ViTAA Medical Solutions

ViTAA Medical Solutions Selected to Receive up to $2M from INOVAIT Focus Fund

ViTAA Medical Solutions was selected to receive up to $2 million from the INOVAIT Focus Fund in July 2023. This funding supports their work in developing AI and diagnostic imaging innovations for more accurate aneurysm assessment.

2023-07

ViTAA Medical Solutions

Dr. Frank J. Veith Joins the Board of Directors of ViTAA Medical Solutions

ViTAA Medical Solutions announced that Dr. Frank J. Veith, a distinguished figure in vascular surgery, joined its Board of Directors in February 2024. Dr. Veith is known for his pioneering work in abdominal aortic endovascular repair.

2024-02

Frequently Asked Questions

What specific products does ViTAA Medical Solutions offer for abdominal aortic aneurysm (AAA) management?

ViTAA offers the AiORTAu2122 platform, which includes AiORTAu2122 Plan for automated preoperative aortic surgery planning, AiORTAu2122 Maps for patient-specific vessel strength analysis, and AiORTAu2122 Watch for longitudinal monitoring and early complication detection. AiORTAu2122 Plan has received FDA 510(k) clearance, while Maps and Watch are currently in multicenter clinical studies.

How does ViTAA Medical Solutions' technology enhance personalized medicine for AAA patients beyond traditional size-based guidelines?

ViTAA's technology moves beyond outdated size guidelines by using AI and diagnostic imaging to assess aneurysms more accurately, providing insights into vessel behavior and identifying vulnerable areas of the aorta with greater precision. Their AiORTAu2122 Maps tool generates a Regional Aortic Weakness (RAW) Score by analyzing CT scans for vessel-integrity insights like thrombus burden. This allows for more informed decision-making throughout the patient journey, potentially enabling earlier intervention for high-risk patients and avoiding unnecessary surgeries for lower-risk ones.

What role do AI, computer vision, and machine learning play in ViTAA's solutions for diagnostic imaging and aortic surgery planning?

ViTAA's solutions leverage AI and computer vision to automatically generate key preoperative measurements from CT scans, such as aneurysm segmentation, centerline generation, and volumetric analysis. This cloud-based approach improves precision and reproducibility in aortic surgical interventions, reduces manual planning work, and provides a 'glassbox' AI model where every step is auditable and understandable by physicians.

What are the compliance and regulatory statuses of ViTAA Medical Solutions' products?

ViTAA Medical Solutions has received FDA 510(k) clearance for its AiORTAu2122 Plan, which is a significant milestone for the company. This clearance validates their approach of combining automation with precision medicine, and the company is also focused on obtaining regulatory approvals in Canada.

How do ViTAA's cloud-based solutions and longitudinal monitoring capabilities benefit patient care and clinical workflows?

ViTAA's AiORTAu2122 platform is a zero-footprint, web-based system that provides automated pre-operative case planning, integrating seamlessly into existing clinical workflows and reducing manual work. The AiORTAu2122 Watch component, currently in clinical studies, is being developed for real-time monitoring of aortic health and long-term post-operative endoleak surveillance and risk stratification, enabling early complication detection and continuous patient-specific vascular care.

What kind of support and partnerships does ViTAA Medical Solutions offer to healthcare providers?

ViTAA Medical Solutions partners with academic institutions like the University of Calgary, where its foundational technology was developed, and has received investment from funds like UCeed. While specific details on customer support were not explicitly found, their focus on integrating into clinical workflows and providing a comprehensive platform suggests a commitment to supporting healthcare providers in adopting their technology. They also exhibit at medical symposiums like VEITHsymposium.

What is the company's stability and funding status?

ViTAA Medical Solutions was founded in 2019 and has secured funding, including a Series A round in January 2025, raising a total of $4.87M. Their FDA 510(k) clearance for AiORTAu2122 Plan in late 2025/early 2026 further indicates significant progress and market entry, suggesting a stable and growing company.

Related Companies

Suggest an Edit → | Report an issue